CN Stock MarketDetailed Quotes
688185 CanSino Biologics Inc.
- 66.50
- +1.00+1.53%
Market Closed Nov 29 15:00 CST
16.46BMarket Cap-22852P/E (TTM)
66.88High63.34Low25.66KlotVolume64.68Open65.50Pre Close168.14MTurnover2.24%Turnover RatioLossP/E (Static)247.45MShares87.5052wk High3.25P/B7.63BFloat Cap37.1252wk Low78.60Limit Up114.78MShs Float797.20Historical High52.40Limit Down5.41%Amplitude37.12Historical Low--Dividend TTM65.53Avg Price12.26KlotAsk--Div YieldTTM100Lot Size12.61KlotBid
CanSino Biologics Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 222.88%567.08M | 1,071.20%303.43M | 13.65%114.28M | -65.49%357.08M | -75.17%175.63M | -95.89%25.91M | -79.86%100.55M | -75.94%1.03B | -77.08%707.4M | -69.45%629.79M |
| Operating revenue | 222.88%567.08M | 1,071.20%303.43M | 13.65%114.28M | -65.49%357.08M | -75.17%175.63M | -95.89%25.91M | -79.86%100.55M | -75.94%1.03B | -77.08%707.4M | -69.45%629.79M |
| Total operating cost | -21.88%735.78M | -28.21%456.33M | -39.32%205.22M | -4.23%1.49B | -0.04%941.84M | -1.64%635.64M | -18.43%338.23M | -37.51%1.55B | -49.21%942.2M | -48.99%646.25M |
| Operating cost | -15.30%146.28M | 4.55%91.45M | -29.08%46.23M | -37.72%259.36M | -28.54%172.72M | -59.69%87.47M | -56.10%65.19M | -67.88%416.44M | -76.91%241.69M | -65.28%217M |
| Operating tax surcharges | 14.15%6.86M | -2.60%4.27M | 1.56%1.97M | -13.47%7.96M | 22.77%6.01M | 52.48%4.38M | 30.23%1.94M | -12.28%9.2M | -42.91%4.9M | -46.69%2.87M |
| Operating expense | 1.24%196.04M | -12.70%112.48M | -15.27%46.59M | 32.55%353.4M | 29.84%193.63M | 44.93%128.84M | 60.25%54.98M | 151.95%266.61M | 132.61%149.14M | 157.07%88.9M |
| Administration expense | -37.57%117.43M | -38.45%83.51M | -38.78%37.07M | 6.55%286.49M | -11.11%188.09M | -0.80%135.67M | -5.54%60.55M | 21.48%268.87M | 49.97%211.61M | 60.75%136.76M |
| Financial expense | 96.12%-3.11M | 64.01%-21.27M | -502.46%-23.38M | 69.53%-56.3M | 62.52%-80.29M | 52.05%-59.1M | -36.14%5.81M | -633.83%-184.74M | -250.27%-214.19M | -257.21%-123.24M |
| -Interest expense (Financial expense) | 3.15%47.41M | 11.78%32.72M | 67.46%14.67M | 55.16%64.15M | 66.83%45.96M | 96.04%29.27M | -7.22%8.76M | 102.46%41.34M | 121.50%27.55M | 125.41%14.93M |
| -Interest Income (Financial expense) | 31.75%-51.32M | 24.92%-38.8M | -4.06%-23.43M | -51.77%-100.06M | -68.53%-75.2M | -86.80%-51.68M | -59.89%-22.52M | 17.23%-65.93M | 28.28%-44.62M | 31.40%-27.66M |
| Research and development | -41.02%272.27M | -45.06%185.9M | -35.40%96.75M | -18.02%637.99M | -15.92%461.67M | 4.45%338.37M | -4.70%149.77M | -11.43%778.26M | -16.27%549.07M | -41.23%323.97M |
| Credit Impairment Loss | 3.99%-13.8M | 30.60%-14.06M | 35.19%-7.25M | -71.43%-15.05M | -129.28%-14.38M | -338.11%-20.26M | -255.74%-11.18M | -381.19%-8.78M | -54.73%-6.27M | -6,149.02%-4.62M |
| Asset Impairment Loss | 98.72%-10.1M | 98.02%-14.09M | -361.32%-7.81M | -20.65%-967.48M | -49.52%-786.74M | -636.64%-711.72M | 43.96%-1.69M | -62,399.07%-801.86M | -83,953.65%-526.18M | -29,812.25%-96.62M |
| Other net revenue | ||||||||||
| Fair value change income | 53.23%-7.19M | -145.47%-4.36M | -129.16%-2.09M | -258.29%-14.56M | -379.50%-15.37M | 13.29%9.6M | 56.11%7.17M | -105.71%-4.06M | -82.25%5.5M | -71.67%8.47M |
| Invest income | -170.34%-50.47M | -244.42%-64.39M | -527.00%-75.39M | -23.72%73.2M | 3.59%71.75M | 29.82%44.59M | 7.53%17.65M | 109.65%95.96M | 140.30%69.27M | 529.52%34.35M |
| -Including: Investment income associates | -280,385.56%-16.25M | -420,600.95%-16.2M | -592,372.18%-13.13M | ---- | --5.8K | --3.85K | --2.22K | ---- | ---- | ---- |
| Asset deal income | -163.08%-23.63K | ---- | ---- | --181.42K | --37.46K | --37.46K | ---- | ---- | ---- | ---- |
| Other revenue | -71.26%27.46M | -54.37%21.06M | -74.26%8.59M | 104.99%119.05M | 103.71%95.52M | 33.77%46.15M | 49.70%33.38M | 287.30%58.08M | 400.48%46.89M | 391.35%34.5M |
| Operating profit | 84.26%-222.83M | 81.57%-228.75M | 9.08%-174.88M | -64.01%-1.94B | -119.24%-1.42B | -2,974.20%-1.24B | -257.82%-192.35M | -160.84%-1.18B | -149.84%-645.59M | -104.83%-40.38M |
| Add:Non operating Income | -97.68%25.81K | -89.03%20.11K | -95.83%2.43K | 264.96%1.1M | 720.13%1.11M | 80.38%183.28K | -6.17%58.17K | -86.22%302.63K | -87.79%135.91K | -61.07%101.61K |
| Less:Non operating expense | -93.06%2.9M | -98.89%470.35K | -99.95%4.15K | 1,110.08%43.52M | 2,894.45%41.81M | 3,201.68%42.19M | 685.44%8.18M | -42.03%3.6M | -76.63%1.4M | 1,751.78%1.28M |
| Total profit | 84.50%-225.7M | 82.14%-229.2M | 12.76%-174.88M | -67.14%-1.98B | -125.10%-1.46B | -2,988.27%-1.28B | -265.82%-200.47M | -161.13%-1.18B | -150.13%-646.85M | -104.97%-41.56M |
| Less:Income tax cost | 228.18%1.49M | 182.81%963.81K | ---- | 94.78%-11.45M | 99.26%-1.16M | 97.98%-1.16M | -558.58%-30.27M | -838.17%-219.24M | -263.56%-158.17M | 42.57%-57.6M |
| Net profit | 84.38%-227.2M | 82.05%-230.16M | -2.75%-174.88M | -103.93%-1.97B | -197.72%-1.45B | -8,092.30%-1.28B | -248.91%-170.2M | -150.59%-964.76M | -136.64%-488.68M | -98.29%16.04M |
| Net profit from continuing operation | 84.38%-227.2M | 82.05%-230.16M | -2.75%-174.88M | -103.93%-1.97B | -197.72%-1.45B | -8,092.30%-1.28B | -248.91%-170.2M | -150.59%-964.76M | -136.64%-488.68M | -98.29%16.04M |
| Less:Minority Profit | 98.98%-4.79M | 98.91%-4.79M | 84.38%-4.79M | -776.08%-484.7M | -3,192.65%-469.89M | -11,685.83%-440.74M | -330.62%-30.65M | -657.48%-55.33M | ---14.27M | --3.8M |
| Net profit of parent company owners | 77.42%-222.41M | 73.22%-225.37M | -21.89%-170.1M | -63.04%-1.48B | -107.63%-985.03M | -6,975.30%-841.43M | -214.94%-139.55M | -147.51%-909.43M | -135.57%-474.41M | -98.69%12.24M |
| Earning per share | ||||||||||
| Basic earning per share | 77.44%-0.9 | 73.31%-0.91 | -21.05%-0.69 | -63.32%-6.01 | -107.81%-3.99 | -6,920.00%-3.41 | -216.33%-0.57 | -147.55%-3.68 | -135.62%-1.92 | -98.68%0.05 |
| Diluted earning per share | 77.44%-0.9 | 73.31%-0.91 | -21.05%-0.69 | -63.32%-6.01 | -107.81%-3.99 | -6,920.00%-3.41 | -216.33%-0.57 | -147.55%-3.68 | -135.62%-1.92 | -98.68%0.05 |
| Other composite income | 210.03%380.75K | 235.35%495.58K | 869.76%322.8K | -346.14%-296.68K | 117.80%122.81K | 147.78K | 33.29K | 120.53K | 56.39K | |
| Other composite income of parent company owners | 210.03%380.75K | 235.35%495.58K | 869.76%322.8K | -346.14%-296.68K | 117.80%122.81K | --147.78K | --33.29K | --120.53K | --56.39K | ---- |
| Total composite income | 84.41%-226.82M | 82.09%-229.67M | -2.58%-174.56M | -103.99%-1.97B | -197.73%-1.45B | -8,091.38%-1.28B | -248.88%-170.17M | -150.58%-964.64M | -136.63%-488.63M | -98.29%16.04M |
| Total composite income of parent company owners | 77.46%-222.03M | 73.27%-224.88M | -21.69%-169.77M | -63.09%-1.48B | -107.63%-984.91M | -6,974.10%-841.28M | -214.91%-139.51M | -147.50%-909.31M | -135.56%-474.35M | -98.69%12.24M |
| Total composite income of minority owners | 98.98%-4.79M | 98.91%-4.79M | 84.38%-4.79M | -776.08%-484.7M | -3,192.65%-469.89M | -11,685.83%-440.74M | -330.62%-30.65M | -657.48%-55.33M | ---14.27M | --3.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data